175 related articles for article (PubMed ID: 36775953)
21. PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.
di Blasio L; Puliafito A; Gagliardi PA; Comunanza V; Somale D; Chiaverina G; Bussolino F; Primo L
Cell Death Dis; 2018 Jan; 9(2):45. PubMed ID: 29352118
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a severe case of PIK3CA-related overgrowth at autopsy by droplet digital polymerase chain reaction and report of PIK3CA sequencing in 22 patients.
Piacitelli AM; Jensen DM; Brandling-Bennett H; Gray MM; Batra M; Gust J; Thaker A; Paschal C; Tsuchiya K; Pritchard CC; Perkins J; Mirzaa GM; Bennett JT
Am J Med Genet A; 2018 Nov; 176(11):2301-2308. PubMed ID: 30063105
[TBL] [Abstract][Full Text] [Related]
23. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
[TBL] [Abstract][Full Text] [Related]
24.
Pagliazzi A; Oranges T; Traficante G; Trapani C; Facchini F; Martin A; Semeraro A; Perrone A; Filippeschi C; Giglio S
Front Pediatr; 2021; 9():732836. PubMed ID: 34568242
[No Abstract] [Full Text] [Related]
25.
Mirzaa G; Timms AE; Conti V; Boyle EA; Girisha KM; Martin B; Kircher M; Olds C; Juusola J; Collins S; Park K; Carter M; Glass I; Krägeloh-Mann I; Chitayat D; Parikh AS; Bradshaw R; Torti E; Braddock S; Burke L; Ghedia S; Stephan M; Stewart F; Prasad C; Napier M; Saitta S; Straussberg R; Gabbett M; O'Connor BC; Keegan CE; Yin LJ; Lai AHM; Martin N; McKinnon M; Addor MC; Boccuto L; Schwartz CE; Lanoel A; Conway RL; Devriendt K; Tatton-Brown K; Pierpont ME; Painter M; Worgan L; Reggin J; Hennekam R; Tsuchiya K; Pritchard CC; Aracena M; Gripp KW; Cordisco M; Van Esch H; Garavelli L; Curry C; Goriely A; Kayserilli H; Shendure J; Graham J; Guerrini R; Dobyns WB
JCI Insight; 2016 Jun; 1(9):. PubMed ID: 27631024
[TBL] [Abstract][Full Text] [Related]
26. Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum.
Michel ME; Konczyk DJ; Yeung KS; Murillo R; Vivero MP; Hall AM; Zurakowski D; Adams D; Gupta A; Huang AY; Chung BHY; Warman ML
Clin Genet; 2018 May; 93(5):1075-1080. PubMed ID: 29231959
[TBL] [Abstract][Full Text] [Related]
27. PIK3CA vascular overgrowth syndromes: an update.
Hughes M; Hao M; Luu M
Curr Opin Pediatr; 2020 Aug; 32(4):539-546. PubMed ID: 32692051
[TBL] [Abstract][Full Text] [Related]
28. Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.
Keppler-Noreuil KM; Lozier J; Oden N; Taneja A; Burton-Akright J; Sapp JC; Biesecker LG
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):571-581. PubMed ID: 31490637
[TBL] [Abstract][Full Text] [Related]
29. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants.
Goss JA; Konczyk DJ; Smits P; Sudduth CL; Bischoff J; Liang MG; Greene AK
Clin Genet; 2020 May; 97(5):736-740. PubMed ID: 31909475
[TBL] [Abstract][Full Text] [Related]
30. CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.
Moneghini L; Tosi D; Graziani D; Caretti A; Colletti G; Baraldini V; Cattaneo E; Spaccini L; Zocca A; Bulfamante GP
Hum Pathol; 2020 May; 99():98-106. PubMed ID: 32272124
[TBL] [Abstract][Full Text] [Related]
31. Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach.
Rodríguez-Laguna L; Davis K; Finger M; Aubel D; Vlamis R; Johnson C
Orphanet J Rare Dis; 2022 May; 17(1):189. PubMed ID: 35526022
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.
Parker VER; Keppler-Noreuil KM; Faivre L; Luu M; Oden NL; De Silva L; Sapp JC; Andrews K; Bardou M; Chen KY; Darling TN; Gautier E; Goldspiel BR; Hadj-Rabia S; Harris J; Kounidas G; Kumar P; Lindhurst MJ; Loffroy R; Martin L; Phan A; Rother KI; Widemann BC; Wolters PL; Coubes C; Pinson L; Willems M; Vincent-Delorme C; ; Vabres P; Semple RK; Biesecker LG
Genet Med; 2019 May; 21(5):1189-1198. PubMed ID: 30270358
[TBL] [Abstract][Full Text] [Related]
33. Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum.
Carli D; Kalantari S; Manicone R; Coppo P; Francia di Celle P; La Selva R; Santoro F; Ranieri C; Cardaropoli S; Fagioli F; Ferrero GB; Resta N; Mussa A
Clin Genet; 2021 Nov; 100(5):624-627. PubMed ID: 34402524
[TBL] [Abstract][Full Text] [Related]
34. Vascular malformations syndromes: an update.
Martinez-Lopez A; Salvador-Rodriguez L; Montero-Vilchez T; Molina-Leyva A; Tercedor-Sanchez J; Arias-Santiago S
Curr Opin Pediatr; 2019 Dec; 31(6):747-753. PubMed ID: 31693582
[TBL] [Abstract][Full Text] [Related]
35. Locally Invasive Papillary Intralymphatic Angioendothelioma Arising Within a Lymphatic/Venous Malformation.
Al-Refai R; Morrar D; Bendari A; Sham S; Unger P; Edelman M
Am J Case Rep; 2023 Oct; 24():e940602. PubMed ID: 37803820
[TBL] [Abstract][Full Text] [Related]
36. Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences.
Dexheimer J; Mirzaa GM
Adv Ther; 2022 Sep; 39(9):3871-3880. PubMed ID: 35857185
[TBL] [Abstract][Full Text] [Related]
37. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.
Kuentz P; St-Onge J; Duffourd Y; Courcet JB; Carmignac V; Jouan T; Sorlin A; Abasq-Thomas C; Albuisson J; Amiel J; Amram D; Arpin S; Attie-Bitach T; Bahi-Buisson N; Barbarot S; Baujat G; Bessis D; Boccara O; Bonnière M; Boute O; Bursztejn AC; Chiaverini C; Cormier-Daire V; Coubes C; Delobel B; Edery P; Chehadeh SE; Francannet C; Geneviève D; Goldenberg A; Haye D; Isidor B; Jacquemont ML; Khau Van Kien P; Lacombe D; Martin L; Martinovic J; Maruani A; Mathieu-Dramard M; Mazereeuw-Hautier J; Michot C; Mignot C; Miquel J; Morice-Picard F; Petit F; Phan A; Rossi M; Touraine R; Verloes A; Vincent M; Vincent-Delorme C; Whalen S; Willems M; Marle N; Lehalle D; Thevenon J; Thauvin-Robinet C; Hadj-Rabia S; Faivre L; Vabres P; Rivière JB
Genet Med; 2017 Sep; 19(9):989-997. PubMed ID: 28151489
[TBL] [Abstract][Full Text] [Related]
38. Intracranial venous malformation masquerading as a meningioma in PI3KCA-related overgrowth spectrum disorder.
Filippidis A; Lidov H; Al-Ibraheemi A; See AP; Srivastava S; Orbach DB; Fehnel KP
Am J Med Genet A; 2022 Mar; 188(3):907-910. PubMed ID: 34854542
[TBL] [Abstract][Full Text] [Related]
39. Shear stress and pathophysiological PI3K involvement in vascular malformations.
Abdelilah-Seyfried S; Ola R
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747293
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar dysplasia related to PIK3CA mutation: a three-case series.
Di Stasi M; Izzo G; Cattaneo E; Baraldini V; Doneda C; Righini A; Graziani D; Toto V; Parazzini C
Neurogenetics; 2021 Mar; 22(1):27-32. PubMed ID: 32901329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]